Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance monensin is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Monensin Monensin A Bovine 2 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics’
10 μg/kg Fat
50 μg/kg Liver
10 μg/kg Kidney
2 μg/kg Milk

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Monensin	Monensin A	Bovine	2 μg/kg	Muscle	NO ENTRY	Anti-infectious agents/Antibiotics’
			10 μg/kg	Fat
			50 μg/kg	Liver
			10 μg/kg	Kidney
			2 μg/kg	Milk